Everlab, the Melbourne-based healthtech startup, has secured US$10 million (AU$15 million) in seed funding to revolutionize preventive healthcare through artificial intelligence. The investment round, led by global growth equity firm Left Lane Capital, will fuel the company's ambitious international expansion plans and accelerate development of its AI-driven health platform.
At the core of Everlab's offering is a proprietary full-stack clinical platform featuring a suite of AI agents that ingest, analyze, and interpret complex health data. These agents automate clinical summaries, identify early risk markers, and recommend personalized interventions, freeing physicians from administrative overhead while enabling earlier, more precise care.
The company operates on a tiered membership model, providing members with comprehensive screening services including advanced blood testing, whole-body MRIs, DEXA scans, and continuous glucose monitoring. This data-driven approach has already demonstrated significant impact, with a meta-analysis showing over one-third of members' modifiable biomarkers improved at the six-month mark.
"We believe everyone deserves access to world-class preventive care," said Marc Hermann, Founder and CEO of Everlab. "By combining AI with the knowledge of leading clinicians, we've built a new kind of health platform designed to deliver smarter, earlier care to millions."
The company's early momentum has been substantial, with tens of thousands of customers on its waitlist and projections for 20x growth this year. To date, Everlab has processed over one million biomarkers through full-body health testing, with alarming results: one in four test results are abnormal, and for 2.5% of members, findings have been life-changing—uncovering serious conditions such as blocked arteries, gastrointestinal tumors, and early-stage cancers.
With this new funding, Everlab will expand its clinic network, grow its engineering and clinical teams, and advance its AI infrastructure—laying the foundation for a global system of preventive healthcare that aims to address the gap in early detection and personalized intervention that remains inaccessible for most people.